- Home
- LENZ vs ORMP Comparison
LENZ vs ORMP Comparison
Compare LENZ & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LENZ | ORMP |
|---|---|---|
| Founded | 2019 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.8M | 165.3M |
| IPO Year | 2021 | 2010 |
Fundamental Metrics
Financial Performance| Metric | LENZ | ORMP |
|---|---|---|
| Price | $5.90 | $4.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $44.00 | N/A |
| AVG Volume (30 Days) | ★ 701.8K | 470.5K |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 0.91 |
| Revenue | ★ $19,088,000.00 | $2,000,000.00 |
| Revenue This Year | $50.42 | N/A |
| Revenue Next Year | $197.16 | N/A |
| P/E Ratio | ★ N/A | $5.05 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $5.23 | $1.98 |
| 52 Week High | $50.19 | $5.19 |
Technical Indicators
Market Signals| Indicator | LENZ | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 36.78 | 60.43 |
| Support Level | $5.23 | $3.69 |
| Resistance Level | $10.42 | $5.10 |
| Average True Range (ATR) | 0.42 | 0.32 |
| MACD | 0.05 | 0.08 |
| Stochastic Oscillator | 35.43 | 58.74 |
Price Performance
Historical ComparisonAbout LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.